Corient Private Wealth’s Arvinas ARVN Stock Holding History

Corient Private Wealth’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,308	Closed	-$109K	–	2994
2026 Q1	$109K	Sell	10,308 -362	-3%	-$4.48K	﹤0.01%	2672
2025 Q4	$127K	Buy	+10,670	New	+$116K	﹤0.01%	2512

Other funds holding ARVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Corient Private Wealth's ARVN Position: Q2 2026 in Review

Corient Private Wealth sold out of Arvinas (ARVN) in Q2 2026, closing a stake of 10,308 shares — an estimated $109K sold.

Corient Private Wealth first reported a position in ARVN in Q4 2025 and held it in 2 quarters. The position peaked at $127K in Q4 2025. 200 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

Corient Private Wealth reported no remaining Arvinas position as of Q2 2026 after selling out during the quarter.
Corient Private Wealth sold 10,308 Arvinas shares in Q2 2026, an estimated $109K.
Corient Private Wealth first reported a position in Arvinas in Q4 2025 and held it in 2 quarters.
Corient Private Wealth's Arvinas position peaked at $127K in Q4 2025.
200 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.